Free for academic non-profit institutions. Other users need a Commercial license
GPR35 (G Protein-Coupled Receptor 35) is a Protein Coding gene. Diseases associated with GPR35 include Cholangitis, Primary Sclerosing and Short-Rib Thoracic Dysplasia 10 With Or Without Polydactyly. Among its related pathways are Signaling by GPCR and Peptide ligand-binding receptors. Gene Ontology (GO) annotations related to this gene include G protein-coupled receptor activity. An important paralog of this gene is GPR55.
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0004930 | G protein-coupled receptor activity | TAS,IDA | 16754668 |
GO:0016494 | C-X-C chemokine receptor activity | IMP | 25411203 |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0005886 | plasma membrane | TAS | -- |
GO:0005887 | integral component of plasma membrane | TAS,IDA | 16754668 |
GO:0016020 | membrane | IEA | -- |
GO:0016021 | integral component of membrane | IEA | -- |
SuperPathway | Contained pathways | ||
---|---|---|---|
1 | Peptide ligand-binding receptors | ||
2 | Signaling by GPCR |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0007010 | cytoskeleton organization | IEA | -- |
GO:0007165 | signal transduction | IEA | -- |
GO:0007186 | G protein-coupled receptor signaling pathway | TAS,IDA | 16754668 |
GO:0007204 | positive regulation of cytosolic calcium ion concentration | IMP | 25411203 |
GO:0035025 | positive regulation of Rho protein signal transduction | IBA | 21873635 |
Name | Status | Disease Links | Group | Role | Mechanism of Action | Clinical Trials |
---|---|---|---|---|---|---|
Furosemide | Approved, Vet_approved | Pharma | Agonist, Target, blocker | GABAA receptors antagonist, Na+/2Cl-/K+ (NKCC) symporter inhibitor. Also antagonizes GABAA | 285 | |
Bumetanide | Approved | Pharma | Agonist, blocker | NKCC cotransporter inhibitor, Na+/2Cl-/K+ (NKCC) symporter inhibitor | 29 | |
Pyrantel | Approved, Vet_approved | Pharma | Target | 24 | ||
Kynurenic acid | Investigational | Pharma | Agonist, Target | 4 | ||
Zaprinast | Pharma | Agonist | phosphodiesterase inhibitor, GPR35 agonist | 0 |
Compound | Action | Cas Number |
---|---|---|
Pamoic acid disodium salt | GPR35 agonist | 6640-22-8 |
TC-G 1001 | GPR35 agonist; more potent than zaprinast (Cat. No. 0947) | 494191-73-0 |
TCS 3035 | GPR35 agonist | 871085-49-3 |
YE 120 | GPR35 agonist | 383124-82-1 |
Zaprinast | GPR35 agonist | 37762-06-4 |
Compound | Action | Cas Number |
---|---|---|
CID 2745687 | GPR35 antagonist | 264233-05-8 |
Pamoic acid disodium salt | 6640-22-8 | |
TC-G 1001 | 494191-73-0 | |
TCS 3035 | GPR35 agonist | 871085-49-3 |
YE 120 | 383124-82-1 | |
Zaprinast | phosphodiesterase inhibitor | 37762-06-4 |
This gene was present in the common ancestor of chordates.
Organism | Taxonomy | Gene | Similarity | Type | Details |
---|---|---|---|---|---|
Chimpanzee (Pan troglodytes) |
Mammalia | GPR35 30 31 |
|
OneToOne | |
Dog (Canis familiaris) |
Mammalia | LOC100855802 30 |
|
||
GPR35 31 |
|
OneToOne | |||
Cow (Bos Taurus) |
Mammalia | GPR35 30 31 |
|
OneToOne | |
Mouse (Mus musculus) |
Mammalia | Gpr35 30 17 31 |
|
OneToOne | |
Rat (Rattus norvegicus) |
Mammalia | Gpr35 30 |
|
||
Platypus (Ornithorhynchus anatinus) |
Mammalia | -- 31 |
|
OneToMany | |
-- 31 |
|
OneToMany | |||
-- 31 |
|
OneToMany | |||
Oppossum (Monodelphis domestica) |
Mammalia | GPR35 31 |
|
OneToOne | |
Chicken (Gallus gallus) |
Aves | GPR35 30 |
|
||
-- 31 |
|
OneToMany | |||
-- 31 |
|
OneToMany | |||
Lizard (Anolis carolinensis) |
Reptilia | -- 31 |
|
OneToMany | |
-- 31 |
|
OneToMany | |||
Zebrafish (Danio rerio) |
Actinopterygii | GPR35 (1 of 3) 31 |
|
OneToMany | |
GPR35 (2 of 3) 31 |
|
OneToMany | |||
GPR35 (3 of 3) 31 |
|
OneToMany |
SNP ID | Clinical significance and condition | Chr 02 pos | Variation | AA Info | Type |
---|---|---|---|---|---|
rs115880579 | Benign: not provided | 240,630,118(+) |
C/T NM_001195381.2(GPR35):c.259C>T (p.Arg87Cys) |
MISSENSE | |
rs13387859 | Benign: not provided. - | 240,630,178(+) |
G/Ap.Val76Met NM_001195381.2(GPR35):c.319G>A (p.Val107Met) |
MISSENSE | |
rs138617727 | Benign: not provided | 240,630,690(+) |
C/T NM_001195381.2(GPR35):c.831C>T (p.Asn277=) |
SYNONYMOUS | |
rs139197368 | Benign: not provided. - | 240,630,037(+) |
G/Ap.Val29Ile NM_001195381.2(GPR35):c.178G>A (p.Val60Ile) |
MISSENSE | |
rs140467268 | Benign: not provided | 240,630,810(+) |
G/A NM_001195381.2(GPR35):c.951G>A (p.Ala317=) |
SYNONYMOUS |
Variant ID | Type | Subtype | PubMed ID |
---|---|---|---|
esv1170354 | CNV | insertion | 17803354 |
esv1425277 | CNV | insertion | 17803354 |
esv2721937 | CNV | deletion | 23290073 |
esv2721938 | CNV | deletion | 23290073 |
esv2721939 | CNV | deletion | 23290073 |
esv2759119 | CNV | gain | 17122850 |
esv29214 | CNV | loss | 19812545 |
esv3389950 | CNV | duplication | 20981092 |
esv3430269 | CNV | duplication | 20981092 |
esv3594806 | CNV | loss | 21293372 |
nsv1001262 | CNV | gain | 25217958 |
nsv10227 | CNV | gain | 18304495 |
nsv1130764 | CNV | deletion | 24896259 |
nsv1136493 | CNV | deletion | 24896259 |
nsv1142405 | CNV | deletion | 24896259 |
nsv1147160 | CNV | deletion | 26484159 |
nsv3240 | CNV | insertion | 18451855 |
nsv460159 | CNV | loss | 19166990 |
nsv470529 | CNV | loss | 18288195 |
nsv584812 | CNV | gain | 21841781 |
nsv584813 | CNV | gain | 21841781 |
nsv584814 | CNV | gain | 21841781 |
nsv584815 | CNV | loss | 21841781 |
nsv820464 | CNV | duplication | 20802225 |
nsv834586 | CNV | loss | 17160897 |
nsv955292 | CNV | deletion | 24416366 |
Disorder | Aliases | PubMed IDs |
---|---|---|
cholangitis, primary sclerosing |
|
|
short-rib thoracic dysplasia 10 with or without polydactyly |
|
|
pseudohypoparathyroidism, type ia |
|
|
vacterl association |
|
|